×

What are you searching for?




Healthcare

4 Min read

Development in migraine treatment meds

Published On 14 Oct 2019 12:12 PM


SHARE THIS ARTICLE  


The medicine and drug industry of the United States has been flourishing and now with the rise of diseases which is due to people’s loss of concern for a healthy life and poor eating habits. The US Food and Drug Administration which administers the drug production and regulation in the country on Friday approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenome....


Tags : United States, US Food and Drug Administration, Reyvow, Division of Neurology Products,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)